The annual Vaccine & ISV Annual Global Congress, co-organized by the Vaccine journal and the International Society for Vaccines (ISV), is the largest non-commercial conference in the vaccine field and attended by vaccine experts and researchers around the world. The journal Vaccine (http://www.journals.elsevier.com/vaccine/) is the pre-eminent journal for those interested in vaccines and vaccination. ISV (http://www.isv-online.org/) is an international organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines. The 7th Vaccine & ISV Annual Global Congress (http://www.vaccinecongress.com/) will be held on October 27-29 , 2013 at Sitges, Barcelona, Spain.
The pre-conference Computational Vaccinology Workshop (ICoVax 2013) will be a satellite workshop held on Oct. 26, 2013, prior to the general Vaccine & ISV Annual Global Congress. The main objective of the ICoVax workshop is to provide an international platform for researchers and bioinformaticians to report, share, and discuss the most recent developments, scientific findings, and ideas in the new exciting field of computational vaccinology and vaccine informatics. This is also a platform for making new friends and building up potential collaborations. The first ICoVax held in 2011 in Seattle, USA, and the second ICoVax2012 in Shanghai China, attracted many attendees worldwide and obtained very positive feedback.
The full-length papers submitted to the ICoVax 2013 workshop through Easychair will be peer-reviewed. Selected top papers will be invited to be revised and published in a peer-review journal. The format of abstract poster presentations is also available. Please check out the Call for Papers page for more detailed information.
Workshop Format and Agenda:
- This will be a full-day workshop. This workshop encourages extensive discussion and exchange. It will include a Morning Session and an Afternoon Session.
- Oral presentations: Each presentation will be restricted to 25 minutes for a full-length paper, and 10 minutes for a flask talk for each presented poster presentation. For the full-length paper presentation, each presenter is required to finish the introductory talk with about 20 minutes, followed by about 5 minutes of discussion. For the short-length paper presentation, approximately 8 minutes will be used for oral presentation and the remaining 2 minutes for discussion. For any presentation which focuses on software development, additional five minutes are given for an onsite software demonstration.
- Tutorial and Software Demo: There will be two sessions of extensive software demos, including EpiVax’ iVAX vaccine design platform.
- Poster sessions: The posters will be available throughout the day. Special poster sessions are allocated in the program.
- Poster size: Our poster board can contain two A0 posters (reference: http://www.papersizes.org/a-paper-sizes.htm). You can use up to an A0 poster size for your poster.
- Discussion: There will be a focused discussion session in the afternoon. Extensive discussions are encouraged during the workshop presentation and breaks.
- Full agenda will be posted soon!
All workshop attendees are expected to have basic understanding in vaccinology, immunology, informatics, and computational biology. All attendees are encouraged to participate in active discussion during the workshop.
- To Register for ICoVax 2013: Email Robyn @ R.Camilleri@elsevier.com
- To Submit Papers to ICoVax 2013: Page to Submit Papers (EasyChair) – Deadline Oct 12th 2013.
- Venue: Meliá Sitges, Barcelona, Spain. Conference Room Details will be posted soon.
- Accommodations: Melia Sitegs Hotel
- Session Program: View Here
Organizing Committee of 3rd ISV ICoVax:
ICoVax is organized by well known experts in the field of computational vaccinology, immunoinformatics, and vaccine informatics. The organization includes the following members:
- Anne S. De Groot, Co-founder, EpiVax, Inc.; Professor and Director, University of Rhode Island Institute for Immunology and Informatics (iCubed)
- Yongqun “Oliver” He, Associate Professor, University of Michigan Medical School, Ann Arbor, USA
- Christian Schoenbach, Professor, Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Fukuoka, Japan
- Nikolai Petrovsky, Professor, Endocrinology Department, Flinders Medical Centre, Bedford Park, SA, Australia.
- Zhiwei Cao, Professor, School of Life Sciences and Technology, Tongji University, Shanghai, China
- Vladimir Brusic, Director of Bioinformatics, Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA, USA.
- Pedro A. Reche, Facultad de Medicina, Dpto. Microbiology I – Immunology, Universidad Complutense de Madrid, Madrid 28040, Spain.